Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation

Cedric Delhaye1, Gabriel Maluenda, Kohei Wakabayashi

  • 1Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, Washington, District of Columbia.

Insights

High preprocedural C-reactive protein (CRP) levels predict a higher risk of death and myocardial infarction after drug-eluting stent (DES) implantation at two years. This association was not observed acutely, suggesting CRP indicates broader cardiovascular risk.

Area of Science:

  • Cardiology
  • Biomarkers
  • Interventional Cardiology

Background:

  • C-reactive protein (CRP) elevation is linked to adverse cardiovascular outcomes post-stenting.
  • Previous data suggest preprocedural CRP may predict events after drug-eluting stent (DES) implantation.

Purpose of the Study:

  • To investigate the association between preprocedural CRP levels and cardiovascular events following DES implantation.
  • To determine if CRP predicts acute versus long-term adverse outcomes post-DES.

Main Methods:

  • Analysis of 936 patients undergoing DES implantation with preprocedural CRP measurements.
  • Patients stratified into tertiles based on CRP levels (<1.31, 1.31-3.76, >3.76 mg/L).
  • Primary endpoint: composite of death and Q-wave myocardial infarction (QWMI) at 2 years; secondary endpoint: target vessel revascularization.

Main Results:

  • No significant difference in death/QWMI among CRP tertiles acutely or at 1 year.
  • At 2 years, death/QWMI occurred in 2.9% (lowest tertile), 5.2% (middle), and 8.8% (highest tertile) (p=0.006).
  • High CRP (upper tertile) was an independent predictor of death/QWMI at 2 years (HR 2.5; p=0.006). Target vessel revascularization rates were similar across groups.

Conclusions:

  • Elevated preprocedural CRP is associated with increased long-term risk of death and QWMI after DES implantation.
  • CRP does not appear to predict acute post-DES complications or target vessel revascularization.
  • High CRP may serve as a marker of overall cardiovascular risk rather than a specific predictor of post-DES events.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...